Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMVAMUNE Smallpox Vaccine in HIV+ and Healthy Subjects
NCT00189904Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Jul 2005
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started Jul 2005; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00189904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189904.